November 6th, 2013
Why Amarin Has To Finish Its Big Fish Oil Study
CardioExchange Editors, Staff
The following post is by Matt Herper, who covers science and medicine for Forbes magazine. When a panel of experts appointed by the Food and Drug Administration said the agency should deny Amarin Pharmaceuticals a broader marketing approval for its fish oil pill Vascepa, the company’s shares tanked 60%, making it the worst-performing biotechnology stock […]
November 5th, 2013
Should You Be Worried About the Treatment for Low-T?
Larry Husten, PHD
The ubiquitous ads ask: “Should I be worried about Low-T”? But now there’s a good chance there’s a more important question: “Should I be worried about the treatment for low-T?” A new study published in JAMA raises the distinct possibility that testosterone therapy may increase the risk for death, heart attack, and stroke. The findings are hardly definitive, but they […]
November 4th, 2013
Healthy Diet in Middle Age Leads to Healthier Old Age
Larry Husten, PHD
New results from a long-running study offer fresh evidence that a “healthy” diet is actually good for you. The study shows that women who followed a healthy diet while in middle age had a much better chance of reaching age 70 without any of the major illnesses or impairments usually associated with old age. In […]
November 4th, 2013
Selections from Richard Lehman’s Literature Review: November 4th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include an observational study of better diet quality and decreased mortality among MI survivors and a clinical review of circulatory shock.
November 4th, 2013
Should Plasma Levels of Dabigatran Guide How We Dose the Drug?
Stuart J Connolly, MD
Stuart J. Connolly discusses his research group’s analysis of data from the RE-LY trial, concerning the relationship between plasma concentrations of dabigatran and the risks for ischemic events and major bleeding.
November 1st, 2013
Hip and Knee Replacements Associated with Lower CV Risk
Total joint arthroplasty was associated with reduced cardiovascular risk among patients with knee or hip osteoarthritis in a BMJ study. Researchers in Canada matched roughly 150 people aged 55 or older with moderate-to-severe knee or hip osteoarthritis who underwent total joint replacement to people with osteoarthritis who did not have surgery. People who underwent arthroplasty […]